Registry of Anesthesia and Perioperative Medicine

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorClinica Alemana de Santiago

About this trial

To assess mortality and morbidity associated to anesthesia interventions

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All individuals

Individuals agreeing to participate in the study by signing a consent

Disqualifiers

The subjects who had insufficient data in their files

Trial population

Individuals of all ages being admitted at Clinica Alemana de Santiago that will require or were in care by an anesthesiologist.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Anesthesia Intervention

    Procedure/Surgery

    Patients exposed to any anesthesia intervention will be assessed to whether the exposure to anesthesia confers a risk for perioperative outcomes

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

All-cause mortality rate in the postoperative period

Posoperative mortality of individuals exposed to any anesthesia related intervention or event

Time frame
30 days
2

All-cause mortality rate in the posoperative period

Posoperative mortality of individuals exposed to any anesthesia related intervention or event

Time frame
one year
3

Number of patients presenting a complication in the posoperative period

Perioperative morbidity of individuals exposed to any anesthesia related intervention or event.

Time frame
30 days
4

Number of patients who needed rehospitalization in the posoperative period

Posoperative rehospitalization rate of individuals exposed to any anesthesia related intervention or event, after primary discharge

Time frame
7 days after primary discharge

Secondary outcomes

1

Change from baseline in pain, as measured by the visual analog scale (VAS)

Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

Time frame
Baseline pre-intervention VAS, postoperative/intervention 1 hour VAS, postoperative/intervention 24 hour VAS
2

Number of patients that develops postoperative acute kidney injury, as measured by Kidney Disease Improving Global Outcomes (KIDGO)-2012 serum creatinine criteria

Criteria for developing acute kidney injury are: Increase in serum creatinin by ≽0.3 mg/dl (≽26.5lmol/l) within 48hours; or Increase in serum creatinine ≽1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or Urine volume \< 0.5ml/kg/h for 6hours.

Time frame
7 and 30 days
3

Number of patients that develops postoperative Major Acute Cardiac Events (MACE), as defined by the American Heart Association

Criteria for MACE are the development of any of the following conditions Non-fatal stroke Non-fatal myocardial infarction Cardiovascular death

Time frame
7 and 30 days
4

Number of patients that develop posoperative chronic pain as measured by visual analog scale

Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

Time frame
3, 6, and 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: